Yargesa
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
42799-709 -
Package NDC
42799-709-15 -
Application number
ANDA209821 -
SPL ID
462f6c9d-b8f1-3a76-e063-6294a90a2b50 -
SPL set ID
2b371dfe-e2b0-47fe-b677-a7bde7149f87 -
UNII
ADN3S497AZ -
RxCUI
401938 -
RxCUI
2642350
What the source publishes
- Labeler
- Edenbridge Pharmaceuticals LLC.
- Active ingredients
- Miglustat
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Yargesa",
"splId": "462f6c9d-b8f1-3a76-e063-6294a90a2b50",
"labels": [
{
"setId": "2b371dfe-e2b0-47fe-b677-a7bde7149f87",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b371dfe-e2b0-47fe-b677-a7bde7149f87",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2b371dfe-e2b0-47fe-b677-a7bde7149f87"
}
],
"routes": [
"ORAL"
],
"labeler": "Edenbridge Pharmaceuticals LLC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (42799-709-15) / 15 CAPSULE in 1 BLISTER PACK",
"package_ndc": "42799-709-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20231031"
}
],
"productId": "42799-709_462f6c9d-b8f1-3a76-e063-6294a90a2b50",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "42799-709",
"deaSchedule": null,
"genericName": "Miglustat",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MIGLUSTAT",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA209821",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200806",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175783",
"N0000020019",
"N0000194077",
"N0000194078"
],
"unii": [
"ADN3S497AZ"
],
"rxcui": [
"401938",
"2642350"
],
"spl_set_id": [
"2b371dfe-e2b0-47fe-b677-a7bde7149f87"
],
"pharm_class_epc": [
"Glucosylceramide Synthase Inhibitor [EPC]",
"Enzyme Stabilizer [EPC]"
],
"pharm_class_moa": [
"Glucosylceramide Synthase Inhibitors [MoA]",
"Enzyme Stabilizers [MoA]"
],
"manufacturer_name": [
"Edenbridge Pharmaceuticals LLC."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:42799-709_462f6c9d-b8f1-3a76-e063-6294a90a2b50"